On Tuesday, Ionis Pharmaceuticals Inc (NASDAQ: IONS) opened higher 0.06% from the last session, before settling in for the closing price of $33.73. Price fluctuations for IONS have ranged from $33.63 to $54.44 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 13.97% over the last five years. Company’s average yearly earnings per share was noted -34.59% at the time writing. With a float of $145.54 million, this company’s outstanding shares have now reached $157.90 million.
The firm has a total of 927 workers. Let’s measure their productivity. In terms of profitability, gross margin is 97.3%, operating margin of -46.12%, and the pretax margin is -44.3%.
Ionis Pharmaceuticals Inc (IONS) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Ionis Pharmaceuticals Inc is 7.83%, while institutional ownership is 98.00%. The most recent insider transaction that took place on Nov 12 ’24, was worth 45,278. In this transaction EVP Research of this company sold 1,194 shares at a rate of $37.92, taking the stock ownership to the 33,713 shares. Before that another transaction happened on Nov 12 ’24, when Company’s Chief Executive Officer sold 6,630 for $38.05, making the entire transaction worth $252,294. This insider now owns 167,393 shares in total.
Ionis Pharmaceuticals Inc (IONS) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -34.59% per share during the next fiscal year.
Ionis Pharmaceuticals Inc (NASDAQ: IONS) Trading Performance Indicators
Check out the current performance indicators for Ionis Pharmaceuticals Inc (IONS). In the past quarter, the stock posted a quick ratio of 8.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.63.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.44, a number that is poised to hit -1.10 in the next quarter and is forecasted to reach -3.43 in one year’s time.
Technical Analysis of Ionis Pharmaceuticals Inc (IONS)
Analysing the last 5-days average volume posted by the [Ionis Pharmaceuticals Inc, IONS], we can find that recorded value of 1.58 million was better than the volume posted last year of 1.32 million. As of the previous 9 days, the stock’s Stochastic %D was 3.17%. Additionally, its Average True Range was 1.30.
During the past 100 days, Ionis Pharmaceuticals Inc’s (IONS) raw stochastic average was set at 2.21%, which indicates a significant decrease from 6.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 36.59% in the past 14 days, which was lower than the 39.85% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $39.15, while its 200-day Moving Average is $43.04. Now, the first resistance to watch is $34.34. This is followed by the second major resistance level at $34.92. The third major resistance level sits at $35.43. If the price goes on to break the first support level at $33.25, it is likely to go to the next support level at $32.74. Now, if the price goes above the second support level, the third support stands at $32.16.
Ionis Pharmaceuticals Inc (NASDAQ: IONS) Key Stats
There are currently 157,897K shares outstanding in the company with a market cap of 5.33 billion. Presently, the company’s annual sales total 787,650 K according to its annual income of -366,290 K. Last quarter, the company’s sales amounted to 133,810 K and its income totaled -140,480 K.
